Ann Hynes
Stock Analyst at Mizuho
(4.16)
# 454
Out of 5,147 analysts
283
Total ratings
61.14%
Success rate
10%
Average return
Main Sectors:
Stocks Rated by Ann Hynes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HCA HCA Healthcare | Maintains: Outperform | $540 → $585 | $529.70 | +10.44% | 24 | Feb 25, 2026 | |
| CRL Charles River Laboratories International | Maintains: Neutral | $215 → $175 | $178.49 | -1.96% | 5 | Feb 20, 2026 | |
| DGX Quest Diagnostics | Maintains: Outperform | $210 → $235 | $211.91 | +10.90% | 17 | Feb 12, 2026 | |
| UNH UnitedHealth Group | Maintains: Outperform | $430 → $350 | $293.27 | +19.34% | 22 | Feb 5, 2026 | |
| SGRY Surgery Partners | Maintains: Outperform | $22 → $19 | $15.50 | +22.58% | 4 | Dec 18, 2025 | |
| FTRE Fortrea Holdings | Maintains: Neutral | $11 → $13 | $10.72 | +21.27% | 6 | Dec 18, 2025 | |
| BTSG BrightSpring Health Services | Maintains: Outperform | $38 → $42 | $41.43 | +1.38% | 3 | Dec 18, 2025 | |
| ARDT Ardent Health | Maintains: Outperform | $20 → $12 | $9.39 | +27.80% | 4 | Dec 18, 2025 | |
| ACHC Acadia Healthcare Company | Maintains: Neutral | $22 → $17 | $23.44 | -27.47% | 13 | Dec 18, 2025 | |
| CVS CVS Health | Maintains: Outperform | $88 → $95 | $79.90 | +18.90% | 12 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $420 → $400 | $320.00 | +25.00% | 6 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $575 → $655 | $451.76 | +44.99% | 5 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $194 → $225 | $239.39 | -6.01% | 16 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $285 → $320 | $289.12 | +10.68% | 16 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $300 → $345 | $190.54 | +81.06% | 9 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $28 → $40 | $44.88 | -10.87% | 9 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $190 → $225 | $178.81 | +25.83% | 13 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $173 → $225 | $108.14 | +108.06% | 16 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $400 → $330 | $154.05 | +114.22% | 9 | Jul 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $15 | $19.85 | -24.43% | 11 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $110 → $120 | $229.23 | -47.65% | 8 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $28 | $23.96 | +16.86% | 1 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $93 → $95 | $107.88 | -11.94% | 8 | Apr 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $370 → $385 | $289.82 | +32.84% | 10 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $175 → $200 | $206.10 | -2.96% | 15 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $242 → $268 | $1.60 | +16,650.00% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $450 → $505 | $987.37 | -48.85% | 19 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $57 | $0.83 | +6,767.47% | 1 | Sep 21, 2017 |
HCA Healthcare
Feb 25, 2026
Maintains: Outperform
Price Target: $540 → $585
Current: $529.70
Upside: +10.44%
Charles River Laboratories International
Feb 20, 2026
Maintains: Neutral
Price Target: $215 → $175
Current: $178.49
Upside: -1.96%
Quest Diagnostics
Feb 12, 2026
Maintains: Outperform
Price Target: $210 → $235
Current: $211.91
Upside: +10.90%
UnitedHealth Group
Feb 5, 2026
Maintains: Outperform
Price Target: $430 → $350
Current: $293.27
Upside: +19.34%
Surgery Partners
Dec 18, 2025
Maintains: Outperform
Price Target: $22 → $19
Current: $15.50
Upside: +22.58%
Fortrea Holdings
Dec 18, 2025
Maintains: Neutral
Price Target: $11 → $13
Current: $10.72
Upside: +21.27%
BrightSpring Health Services
Dec 18, 2025
Maintains: Outperform
Price Target: $38 → $42
Current: $41.43
Upside: +1.38%
Ardent Health
Dec 18, 2025
Maintains: Outperform
Price Target: $20 → $12
Current: $9.39
Upside: +27.80%
Acadia Healthcare Company
Dec 18, 2025
Maintains: Neutral
Price Target: $22 → $17
Current: $23.44
Upside: -27.47%
CVS Health
Dec 10, 2025
Maintains: Outperform
Price Target: $88 → $95
Current: $79.90
Upside: +18.90%
Nov 4, 2025
Maintains: Outperform
Price Target: $420 → $400
Current: $320.00
Upside: +25.00%
Oct 24, 2025
Maintains: Outperform
Price Target: $575 → $655
Current: $451.76
Upside: +44.99%
Oct 17, 2025
Maintains: Outperform
Price Target: $194 → $225
Current: $239.39
Upside: -6.01%
Oct 17, 2025
Maintains: Outperform
Price Target: $285 → $320
Current: $289.12
Upside: +10.68%
Oct 9, 2025
Maintains: Outperform
Price Target: $300 → $345
Current: $190.54
Upside: +81.06%
Oct 9, 2025
Maintains: Neutral
Price Target: $28 → $40
Current: $44.88
Upside: -10.87%
Jul 25, 2025
Maintains: Outperform
Price Target: $190 → $225
Current: $178.81
Upside: +25.83%
Jul 25, 2025
Maintains: Outperform
Price Target: $173 → $225
Current: $108.14
Upside: +108.06%
Jul 11, 2025
Maintains: Outperform
Price Target: $400 → $330
Current: $154.05
Upside: +114.22%
Nov 19, 2024
Maintains: Neutral
Price Target: $13 → $15
Current: $19.85
Upside: -24.43%
Nov 4, 2024
Maintains: Neutral
Price Target: $110 → $120
Current: $229.23
Upside: -47.65%
Aug 19, 2024
Initiates: Outperform
Price Target: $28
Current: $23.96
Upside: +16.86%
Apr 25, 2024
Maintains: Buy
Price Target: $93 → $95
Current: $107.88
Upside: -11.94%
Mar 8, 2024
Maintains: Buy
Price Target: $370 → $385
Current: $289.82
Upside: +32.84%
Mar 6, 2024
Maintains: Buy
Price Target: $175 → $200
Current: $206.10
Upside: -2.96%
Feb 23, 2024
Maintains: Buy
Price Target: $242 → $268
Current: $1.60
Upside: +16,650.00%
Feb 9, 2024
Maintains: Neutral
Price Target: $450 → $505
Current: $987.37
Upside: -48.85%
Sep 21, 2017
Initiates: Neutral
Price Target: $57
Current: $0.83
Upside: +6,767.47%